About: HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Peter B Gilbert et al published 22 May 2019 in BMC Infectious Diseases

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) im Mai 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в травні 2019 (uk) scholarly article by Peter B Gilbert et al published 22 May 2019 in BMC Infectious Diseases (en)
publication date	wds:Q64276594-15D368A6-FBD0-4679-998E-C7D9F2EC08F8
publication date	2019-05-22 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64276594-15003979-05EC-43F7-81C1-F4FEC767652C
language of work or name	English
cites work	wds:Q64276594-06D3BA9E-B908-4D0A-BB65-D463E3C8558B wds:Q64276594-075CD08D-5DB1-460F-9690-A78D021A501F wds:Q64276594-0889A500-2657-4E57-85E4-76F680F8C910 wds:Q64276594-0D07AEC1-1D2E-4226-8E60-BC03D12DB2EB wds:Q64276594-0DC7FA2A-9ED4-4B81-BE0A-F3FE49032599 wds:Q64276594-200801DA-8C83-4EC9-BE3F-001C02DC2CB1 wds:Q64276594-25D4B4F9-7B9F-4D98-9F2B-3CE0DFC17E8A wds:Q64276594-3129FE6B-14A5-4427-BD57-B08B2EEA8926 wds:Q64276594-3A75BF5D-E29B-4106-88EF-312F40D9538A wds:Q64276594-3BE55FCB-C4A4-45BC-BFE4-48170E7E6B04 wds:Q64276594-3F5E688D-21F6-4CF8-9F82-C40AE6669A2C wds:Q64276594-3FCAB6A9-4402-4AF0-86EE-D4C24DEF44C8 wds:Q64276594-449C1EAA-9EEF-418D-BC21-8BFDF107D7E6 wds:Q64276594-50868655-D65D-426B-9FB6-8560AE0819E6 wds:Q64276594-51E567D2-3A5B-4A91-9239-5313A0B6322A wds:Q64276594-5426B5A8-B489-4A6C-84EB-4F6CC8E2B527 wds:Q64276594-5460BF5E-4792-4B68-85CF-6C0C5867F7E7 wds:Q64276594-55D08F83-EC62-4568-8D34-6139670C38CF wds:Q64276594-59C2F988-FE42-4F76-B43F-A44D420E425C wds:Q64276594-5AC307F1-CC36-4AAA-A187-34821652A847 wds:Q64276594-5BCE6906-3392-47FA-8B89-60FE6EA3C5A6 wds:Q64276594-6A469EE1-66B8-45BF-8489-414F25F1B960 wds:Q64276594-775314B8-13B3-4E27-B159-16A62E2071DB wds:Q64276594-7818368B-C700-4C33-8660-B112A60AE4BD wds:Q64276594-7868340A-2050-4978-AFAD-39DBF7C7E54A wds:Q64276594-7E2F0781-2771-4699-837B-086224D595D9 wds:Q64276594-7F6C166D-CB0C-4286-BCE9-4159BE8362E2 wds:Q64276594-840FD441-2976-4A2D-A51E-56E47AA071FC wds:Q64276594-8860B413-DBA7-4997-B444-2702D1D85A65 wds:Q64276594-8AD544F1-0D2E-4397-B815-43312BA3B0DB wds:Q64276594-8C4D9FE1-3E1B-4CC1-B1A0-6AF2692C4745 wds:Q64276594-95AFC926-453A-4D81-A0D3-8E871DCF7A93 wds:Q64276594-99ADD21D-292F-4C47-A837-10ABDCBC59B5 wds:Q64276594-A6BECACE-8F35-482C-9117-F56CE8AA9754 wds:Q64276594-AA505741-DC3E-4FC2-8D76-CE78ED8E3E89 wds:Q64276594-AB8015CB-5933-4F24-92E9-9036072E02B3 wds:Q64276594-ACB1F9B5-E25A-41BC-A151-59ED95836D05 wds:Q64276594-AF434362-3448-4336-9ABD-ADB66A5D036B wds:Q64276594-B6AF3E72-BCF8-4A1A-B1C1-B7BF533FF80A wds:Q64276594-BAF2F4B1-9B90-4289-B48D-1BDB215CA313 wds:Q64276594-C9457894-224D-43B8-9BE6-F30BCA2BF245 wds:Q64276594-CFE2BF69-468B-45C5-ACCB-DE1233D4EF2D wds:Q64276594-D1A0B56D-1315-4991-B97F-BB3BB45271CC wds:Q64276594-E289657B-82F8-4CEF-8CC4-3ED4FF06B084 wds:Q64276594-E4D7CB9E-4573-4A3B-9560-EA0C9CF0B354 wds:Q64276594-E52F244D-F913-46BD-A50A-D7041ED5336A wds:Q64276594-E87DE61E-60CF-4680-8D56-E29EB181C232 wds:Q64276594-EF0DD016-9E60-46A3-B800-CD174357D0C6 wds:Q64276594-F0EE4549-A877-4941-A04C-F5D13DACD3DC wds:Q64276594-F1423331-51F9-49CC-8A78-0761A6475F55 wds:Q64276594-F31036AD-7CC5-46E9-BD90-155E99E35A56 wds:Q64276594-F47A6940-32A8-4578-A71A-CC4217E1C484 wds:Q64276594-F49A1517-F2E7-4B29-B31F-DC25BA3EE6A3 wds:Q64276594-FA212FA9-2B11-45C7-95EE-950B3D5D4588 wds:Q64276594-FB954AD4-E913-4DE1-B013-C0ABC3229DB0 wds:Q64276594-FC5F2828-6B3D-492B-B0C9-31871231EF38
cites work	Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus Quantifying influenza vaccine efficacy and antigenic distance. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness Attacking the flu: neutralizing antibodies may lead to 'universal' vaccine Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection Principal stratification in causal inference Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model Surrogate endpoints in clinical trials: definition and operational criteria Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults Variable efficacy of repeated annual influenza vaccination Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital Influenza vaccine: the challenge of antigenic drift. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. Global analyses of human immune variation reveal baseline predictors of postvaccination responses Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains Determinants of immunity to influenza infection in man Augmented designs to assess immune response in vaccine trials Evaluating candidate principal surrogate endpoints Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults Serologic assays for influenza surveillance, diagnosis and vaccine evaluation Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus Influence of prior influenza vaccination on antibody and B-cell responses Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons Influenza vaccine effectiveness in the community and the household Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software